NOVO NORDISK INC.

Lobbying for NOVO NORDISK INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $1,290,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

S 150
Combating Cartels on Social Media Act of 2025

Lobbying activity 6

Health Issues

Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation and drug pricing legislation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding

Budget/Appropriations

Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding, FDA Agricultural Appropriations bill

Medicare/Medicaid

Obesity, Treat and Reduce Obesity Act, IRA implementation, General engagement around drug pricing

S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding

Taxation/Internal Revenue Code

International and corporate tax issues

Tariff (miscellaneous tariff bills)

Tariffs and trade policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.